Coronavirus Updates: Serum Institute says India vaccine trials will resume after DCGI's nod
Fp Staff • .Coronavirus LIVE Updates: The Serum Institute of India (SII) on Saturday said, "Once DCGI (Drugs Controller General of India) gives us permission to restart the trials in India, we will resume the trials."